Clinical Trial Update: MLX/XLX ACR Expandable Lumbar Interbody Implants

View source ↗

Summary

NuVasive reports completion of a clinical trial evaluating the MLX/XLX ACR Expandable Lumbar Interbody Implants for degenerative disc disease, spondylolisthesis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Degenerative Scoliosis
• Spondylolisthesis

Drugs mentioned

• MLX/XLX ACR Expandable Lumbar Interbody Implants

Snippet

Sponsor: NuVasive | Conditions: Degenerative Disc Disease, Spondylolisthesis | Status: COMPLETED